Compare Subjective Drug Liking & Pharmacokinetics of Vyvanse™ and ADDERALL XR® When Administered as an Oral Solution
Clinical trial NCT00776555 · TERMINATED
Trial details
- NCT number
- NCT00776555
- Sponsor
- Shire
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-21
- Primary completion
- 2009-03-31
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.